Latest news in digitalcare

AI's Role in Revolutionizing Real-Time Patient Monitoring

AI's Role in Revolutionizing Real-Time Patient Monitoring

United States, Saturday, 29 March 2025.
Artificial intelligence is transforming healthcare by enabling precise real-time monitoring through wearables, projected to drive the AI healthcare market toward $630.92 billion by 2033.

Scalable Pediatric Telemedicine Pathways: Challenges and Insights

Scalable Pediatric Telemedicine Pathways: Challenges and Insights

Global, Friday, 28 March 2025.
The report discusses pathways for integrating pediatric telemedicine and medication delivery in healthcare, revealing challenges like virtual exam reliability and long-term sustainability.

Wellola and Org Forge Partnership to Revolutionize Healthcare Digitization

Wellola and Org Forge Partnership to Revolutionize Healthcare Digitization

United Kingdom, Friday, 28 March 2025.
Wellola and Org launch a powerful digital healthcare solution for NHS and private providers, leveraging Wellola’s technology and Org’s expertise to lead patient management and engagement.

AI-Driven Heart Analysis Revolutionizes Treatment for Heart Disease

AI-Driven Heart Analysis Revolutionizes Treatment for Heart Disease

Online, Friday, 28 March 2025.
Cleerly employs AI for non-invasive heart assessments, advancing personalized medicine with better risk evaluation and treatment strategies for heart disease patients.

CFC's Innovative eHealth Policy: Insights from Rebecca Pelling

CFC's Innovative eHealth Policy: Insights from Rebecca Pelling

United Kingdom, Thursday, 27 March 2025.
Rebecca Pelling discusses CFC’s pioneering eHealth policy amid digital healthcare’s growth, highlighting tech trends like telemedicine and AI impacting insurance coverage strategies.

DEA Extends Telemedicine Rule Implementation to End of 2025

DEA Extends Telemedicine Rule Implementation to End of 2025

United States, Thursday, 27 March 2025.
The DEA has delayed two telemedicine rules’ effective dates, allowing the current remote prescribing waivers to continue until December 31, 2025, giving stakeholders extra adaptation time.

J&J's Rybrevant-Lazcluze Combination Shows Promising Survival Rates in Lung Cancer Trial

J&J's Rybrevant-Lazcluze Combination Shows Promising Survival Rates in Lung Cancer Trial

New Brunswick, Thursday, 27 March 2025.
Johnson & Johnson’s Rybrevant-Lazcluze combination significantly extends survival for EGFR-mutated lung cancer, reducing death risk by 25% compared to AstraZeneca’s Tagrisso, offering hope in cancer treatment advancements.

New York Advances Healthcare Access Through Telemedicine Expansion

New York Advances Healthcare Access Through Telemedicine Expansion

New York, Thursday, 27 March 2025.
United Health Services (UHS) broadens telemedicine options, enhancing healthcare access across New York with modern digital platforms, addressing geographic and logistical barriers to equitable care.

Nexus 2025: Shaping the Future of Digital Health in New Orleans

Nexus 2025: Shaping the Future of Digital Health in New Orleans

New Orleans, Wednesday, 26 March 2025.
Nexus 2025, held from May 3-6 in New Orleans, invites over 5,000 health and tech professionals to discuss AI-driven virtual care and digital innovations, fostering cross-sector collaborations.

Kaiser Permanente Sets Ethical AI Guidelines for Healthcare

Kaiser Permanente Sets Ethical AI Guidelines for Healthcare

Oakland, Wednesday, 26 March 2025.
Kaiser Permanente introduces seven principles for responsible AI use in healthcare, focusing on privacy, reliability, and equity to balance innovation with patient care.